Covid-19: Five held in Bengaluru for black marketing of Remdesivir

Bengaluru police have arrested five persons for selling Remdesivir injections at eight to 10 times more than the prescribed rates of the antiviral drug

Remdesivir, coronavirus, covid-19, drugs, medicine, health
IANS Bengaluru
2 min read Last Updated : May 09 2021 | 7:09 AM IST

In two separate incidents, Bengaluru police have arrested five persons for selling Remdesivir injections at eight to 10 times more than the prescribed rates of the antiviral drug, the police said on Saturday.

Bengaluru North division police arrested these five persons in two separate incidents. In the first case, four persons were arrested from the Mahalakshmi Layout police limits, while another person was arrested from the Sriramapura police limits.

The police identified the accused persons as Shivakumar, 32, a bank manager in the cooperative sector; Darshan, 29, a medical representative; Girish, 30, a lab technician, and Nagesh, 43, a vegetable vendor.

The fifth arrested person has been identified as Nayaz Ahmed, 30, an employee with an online pharma delivery company.

The police said that all these accused persons were selling the drug for as high as Rs 35,000 to Rs 40,000 per vial.

The accused bank manger used the gullible vegetable vendor to sell these vials by making the purchasers believe that he was in possession of them as one of his relatives died of Covid recently and the family was in possession of these medicines and all he wanted was to sell them at a price at which he had reportedly purchased them.

"The lab technician working in a hospital used to send customers to him," the police said.

In the Srirampuram case, the medicine delivery boy had purchased vials MRP from a commissioning agent stating that he wanted the medicine to treat his brother.

In Karnataka, the price of Remdesivir ranges between Rs 899 and Rs 5,400 per vial. According to the available statistics, the retail price (MRP) for per vial for various brands of Remdesivir is Rs 5,400 for Hetero company, Rs 4,700 for Mylan, Rs 4,700 for Jubliant, Rs 5,400 for Reddy's, Rs 4,000 for Cipla and Rs 899 for Zydus.

--IANS

nbh/arm

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLockdownCoronavirus VaccineCoronavirus TestsRemdesivir

First Published: May 09 2021 | 6:58 AM IST

Next Story